EDGAR Filing Documents for 0001493152-21-009966

Form 424B4 - Prospectus [Rule 424(b)(4)]:

SEC Accession No. 0001493152-21-009966

Filing Date

2021-04-28

Accepted

2021-04-28 17:29:26

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		form424b4.htm	424B4	1644456
2		form424b4_001.jpg	GRAPHIC	7111
3		img_003.jpg	GRAPHIC	20507
4		img_004.jpg	GRAPHIC	17302
5		img_005.jpg	GRAPHIC	122365
6		img_006.jpg	GRAPHIC	38429
	Complete submission text file	0001493152-21-009966.txt		1929575

Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010

Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200

Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)